Cognitive Remediation

You are here

Dr. Jessica Spat-Lemus and Amanda Sacks-Zimmerman
Dr. Jessica Spat-Lemus and Amanda Sacks-Zimmerman

The Weill Cornell Brain and Spine Center now offers a comprehensive Cognitive Remediation Program that focuses on improving working memory, attention, and focus. 

The Cognitive Remediation Program is designed for anyone who experiences difficulty staying on task, managing deadlines and projects, and maintaining focus in conversations with others. These are all common symptoms of deficits in working memory, which can be caused by any number of things, including epilepsy, surgery, neurovascular disorders, chemotherapy, and other medical conditions.

Clinical neuropsychologists Amanda Sacks-Zimmerman, Ph.D., ABPP-CN, and Jessica Spat-Lemus, Ph.D., members of the Weill Cornell Brain and Spine Center faculty, provide services to patients in the Cognitive Remediation Program. For more information, contact Dr. Sacks-Zimmerman at 212-746-3356, Dr. Spat-Lemus at 646-962-3336, or use our online form to request an appointment.

NEW! Group Cognitive Remediation Therapy
The Weill Cornell Medicine Brain and Spine Center now offers cognitive remediation in a group setting for patients who have experienced a cerebrovascular accident (stroke, aneurysm, or other event). Others who have had such an accident know better than anyone how confusing its cognitive after-effects may be. Going through remediation as part of a group allows you to get the help you need in the company of others who understand what you’ve been through.

A group setting allows you to receive and provide feedback on strategies that work best, as well as encouragement to help you along your journey. Learning these new strategies in a group reduces the sense of isolation that often accompanies cognitive dysfunction.

FOR MORE INFORMATION, OR TO ENROLL IN THE NEXT GROUP: Call 212-746-3356

Clinical Study: A new study underway at the Weill Cornell Brain and Spine Center evaluates the effectiveness of computerized cognitive remediation on survivors of low-grade gliomas. To see if you are eligible for the study, contact Dr. Sacks-Zimmerman at 212-746-3356.